1Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis, 2002, 22: 145-155.
2Amacher DE. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol, 1998, 27:119-130.
3Andrade RJ, Lucena MI, Pachkoria K, et al. Chronic liver damage after an episode of idiosyncratic drug induced liver injury (DILI). J Hepatol, 2006, 44(suppl 2):S247.
4Nathwani RA, Kaplowitz N. Drug hepatotoxicity. Clin Liver Dis, 2006, 10:207-217.
5Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990, 11 : 272-276
6Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf, 2007, 30:277-294.
7Temple R. Hy's law: predicting serious hepatotoxicity. Pharmaco epidemiol Drug Saf, 2006, 15 : 241-243.
8Poison J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology, 2005, 41 : 1179-1197.
9Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med, 2006, 354:731-739.
10Aithal GP, Rawlins MD, Day CP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol, 2000, 33:949-952.
